452 results on '"Palmieri, Giovannella"'
Search Results
2. DLL3 as a potential diagnostic and therapeutic target in neuroendocrine neoplasms: A narrative review
3. Impaired Seroconversion After Severe Acute Respiratory Syndrome Coronavirus 2 mRNA Vaccine in Patients With Thymic Epithelial Tumors
4. Exploring the interplay between Kaposi's sarcoma and SARS‐CoV‐2 infection: A case series and systematic review.
5. Case report: Potential role of immunotherapy in thymic malignancies: a unique case of a durable and complete response upon an immune checkpoint inhibitor.
6. Serum biomarkers of inflammation and vascular damage upon SARS-Cov-2 mRNA vaccine in patients with thymic epithelial tumors
7. Recommendations for surveillance and follow-up of men with testicular germ cell tumors: a multidisciplinary consensus conference by the Italian Germ cell cancer Group and the Associazione Italiana di Oncologia Medica
8. AB012. The potential role of innate lymphoid cells in thymic epithelial tumors
9. AB003. Unexpected long-lasting control of thymic carcinoma treated with anti-PD1 and oral etoposide: a real-life experience of combination therapy
10. AB013. Occurrence and severity of COVID-19 in patients affected by thymic epithelial tumors with or without Good’s syndrome: a single centre experience
11. Immunocytometric analysis of patients with thymic epithelial tumors revealed that COVID-19 vaccine booster strongly enhanced the immune response
12. Systemic treatment of malignant gastrointestinal neuroectodermal tumour after childhood neuroblastoma: chemotherapy in malignant gastrointestinal neuroectodermal tumour
13. Shifting from a Biological-Agnostic Approach to a Molecular-Driven Strategy in Rare Cancers: Ewing Sarcoma Archetype
14. Multidisciplinary approach for rare thoracic tumors during COVID-19 pandemic
15. The European Reference Network: the keystone for the management of rare thoracic cancers
16. Extraskeletal Ewing’s sarcoma of the mediastinum: Case report
17. The unusual first sign of presentation of renal cell carcinoma: a rare case report
18. Complementary Treatments in Thymic Neoplasms: Steroids and Octreotide
19. Immunological signature of patients with thymic epithelial tumors and Good syndrome
20. Impaired seroconversion after SARS-COV-2 mRNA vaccine in patients with thymic epithelial tumors.
21. Immunological signature of patients with thymic epithelial tumors.
22. A comprehensive outlook on intracerebral therapy of malignant gliomas
23. Heterogeneity of SSTR2 Expression Assessed by 68Ga-DOTATOC PET/CT Using Coefficient of Variation in Patients with Neuroendocrine Tumors
24. The Never-Ending History of Octreotide in Thymic Tumors: A Vintage or A Contemporary Drug?
25. AB009. Pitfalls in mediastinal masses diagnosis
26. AB010. Incidental discovery of thymic masses during syndrome coronavirus type 2 (SARS-CoV-2) infection
27. AB008. Synchronous thymic and breast malignancies: a single institutional experience
28. AB007. Preliminary data of immunogenicity of SARS-COV-2 mRNA vaccine in thymic epithelial tumors
29. Results of TETimaX Trial of Langerhans Cell Histiocytosis Treatment and Perspectives on the Role of Imatinib Mesylate in the Era of MAPK Signaling
30. Heterogeneity of SSTR2 expression assessed by 68Ga-DOTATOC-PET/CT using coefficient of variation in patients with neuroendocrine tumors.
31. The Enigmatic Role of TP53 in Germ Cell Tumours: Are We Missing Something?
32. Imatinib mesylate in thymic epithelial malignancies
33. Sorafenib plus octreotide is an effective and safe treatment in advanced hepatocellular carcinoma: multicenter phase II So.LAR. study
34. Zoledronic acid in the treatment of bone metastases by hepatocellular carcinoma: a case series
35. Zoledronic acid in treatment of bone lesions by Langerhans cell histiocytosis
36. ☆Corrigendum to “Recommendations for surveillance and follow-up of men with testicular germ cell tumors: A multidisciplinary consensus conference by the Italian Germ cell cancer Group and the Associazione Italiana di Oncologia Medica” [Crit. Rev. Oncol. Hematol. 137 (2019) (May) 154–164]
37. Pneumonitis in patients with thymoma and Good's syndrome.
38. Phase II study of temozolomide plus pegylated liposomal doxorubicin in the treatment of brain metastases from solid tumours
39. Large retroperitoneal lymphadenopathy and increased risk of venous thromboembolism in patients receiving first-line chemotherapy for metastatic germ cell tumors: A study by the global germ cell cancer group (G3)
40. A New Horizon of Liquid Biopsy in Thymic Epithelial Tumors: The Potential Utility of Circulating Cell-Free DNA
41. In Reply
42. Sorafenib in advanced iodine-refractory differentiated thyroid cancer: efficacy, safety and exploratory analysis of role of serum thyroglobulin and FDG-PET
43. Cisplatin and 5-fluorouracil in inoperable, stage IV squamous cell carcinoma of the penis
44. Phase II study of docetaxel re-treatment in docetaxel-pretreated castration-resistant prostate cancer
45. Impact of COVID-19 outbreak on cancer immunotherapy in Italy: a survey of young oncologists
46. Thymic Epithelial Tumors as a Model of Networking: Development of a Synergistic Strategy for Clinical and Translational Research Purposes
47. Mediastinal soft tissue sarcoma: dark sides and future lights
48. Low-dose oral etoposide is an active option for patients with heavily pre-treated thymic epithelial tumors.
49. Update of NGS analysis of Italian survey of second tumors in patients with diagnosis of GIST (gastrointestinal stromal tumor).
50. Platinum drug sensitivity and resistance in testicular germ cell tumors: two sides of the same coin
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.